Sterile compounding pharmacies, whether small 503A hospital facilities or large 503B GMP-compliant
outsourcing sites, face increasing pressure to meet evolving quality standards while protecting patients from microbial contamination.
No matter the size of the facility, microbial detection, identification, and endotoxin testing remain essential for preventing risk and maintaining compliance. Strengthen your contamination control plan with modern, compliant, and efficient QC testing strategies designed to support consistent product safety and regulatory confidence.
Uncover the Insights



